Dyslipidaemias are alterations to the plasma lipid profile that are often associated with
clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are …

Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Abstract The Korea National Health and Nutrition Examination Survey (KNHANES) was
initiated in 1998 to provide evidence for the development and evaluation of health policies …

High blood cholesterol is typically considered a feature of wealthy western countries,.
However, dietary and behavioural determinants of blood cholesterol are changing rapidly …

Background and aims Lipid-modifying agents (LMAs) are increasingly used to reduce lipid
levels and prevent cardiovascular events but the magnitude of their consumption in different …

Background Dyslipidemia is a crucial risk factor for cardiovascular diseases. Previous
studies have suggested that air pollution is associated with blood lipids. However, little …

Background and aims Central and Eastern Europe (CEE) is a largely understudied region,
despite having the highest cardiovascular disease mortality in Europe. This analysis aimed …

Background and aims The epidemiological characteristics of MAFLD and its relationship
with atrial fibrillation (AF) are limited in China. Therefore, we explored the epidemiological …

Background A distorted blood lipid profile is an important risk factor for ischemic heart
disease (IHD) but the predictive ability of the different lipid measures has rarely been …